Application no. and date | 13800883.4 (espacenet) (Federated) (European Patent Register), 20130605 | Patent/reg. no. and date | DK/EP 2858640, 20200325 | Publication date | 20150415 | Priority no. and date | US 201261656451 P, 20120606 | EP pub. no. and date |
EP 2858640 20150415 | Effective date | | Applicant/owner | Nalpropion Pharmaceuticals LLC, 10 North Place Park, Suite 201
Morristown, NJ 07960, US | Applicant ref. no. | P73399DK01 | Inventor | KLASSEN, Preston, 7762 Lookout Drive
La Jolla, CA 92037, US, TAYLOR, Kristin, 15023 Palomino Mesa Road
San Diego, CA 92127, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/137 (2006.01) , A61K 31/485 (2006.01) , A61K 9/20 (2006.01) , A61P 3/04 (2006.01) , A61P 9/00 (2006.01) , A61P 9/04 (2006.01) , A61P 9/10 (2006.01) , G01G 19/414 (2006.01) , G09B 19/00 (2006.01) , G09B 5/06 (2006.01) | Title | Sammensætning til anvendelse i en fremgangsmåde til behandling af overvægt og fedme hos patienter med høj cardiovaskulær risiko | Int. application no. | US2013044368 | Int. publication no. | WO2013184837 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|